With Evo 2, researchers can rapidly predict protein structures and generate DNA sequences, significantly advancing the fields ...

PepGen Inc. , a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological ...

Kokoris came up with the idea of solving some of the noise issue of nanopore sequencing by converting DNA into larger ...

Three research teams have been selected as recipients of the 2024 Blavatnik Therapeutics Challenge Awards, an annual awards ...

Three research teams have been selected as recipients of the 2024 Blavatnik Therapeutics Challenge Awards, an annual awards ...

The CBSE Class 12 Chemistry Exam 2025 is set for February 27, 2025, and as the exam approaches, strategic revision is crucial for scoring high marks. To assist students in their last-minute ...

Researchers begin with a long strand of DNA, the scaffold, in solution. Because the nucleotide bases that make up DNA bind in a known way (adenine binds to thymine, and guanine binds to cytosine), the ...

LETI-101 has demonstrated therapeutically relevant reductions of mutant huntingtin (HTT) protein, exceeding 80%, while preserving essential ...

Department of Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine, 725 North Wolfe Street, Baltimore, Maryland 21205, United States ...

These are either (1) adenine, or (2) thymine, or (3) guanine, or (4) cytosine with sugar and phosphate molecules attached to them. Thus the hereditary properties of any given organism could be ...